Subtype
Malignant Female Reproductive System Neoplasm
CI-CAN-00003157Explore in graph →
1,464 active trials11 approved drugs128 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003157Explore in graph →
Clinical trials
6,254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (740)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04332653 | NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 215 | NeoImmuneTechINDUSTRY | 1 | Mar 9, 2026 | clinicaltrials |
| NCT04423679 | The Selfie Study- Assessing Novel Markers for Cervical Cancer Screening From Self-collected Samples(SELFIE) | completed | — | 294 | George Washington UniversityOTHER | 1 | Mar 6, 2026 |
| clinicaltrials |
| NCT06184867 | Choices About Genetic Testing And Learning Your Risk With Smart Technology(CATALYST) | completed | N/A | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Mar 6, 2026 | clinicaltrials |
| NCT04024254 | A Study of Serum Folate Levels in Patients Treated With Olaparib | completed | Phase 4 | 10 | Rush University Medical CenterOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT05035173 | The LYSA (Linking You to Support and Advice) Trial(LYSA) | completed | N/A | 200 | University College CorkOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT06624878 | Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer | completed | N/A | 568 | Zhejiang Cancer HospitalOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT07439328 | ASTRA Study: Circulating Tumor Cells in Blood of Patients With High-Grade Serous Ovarian Cancer | completed | N/A | 30 | Institute of Oncology LjubljanaOTHER | 1 | Feb 27, 2026 | clinicaltrials |
| NCT04697628 | Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer(innovaTV 301) | completed | Phase 3 | 502 | Seagen, a wholly owned subsidiary of PfizerINDUSTRY | 25 | Feb 24, 2026 | clinicaltrials |
| NCT06711380 | Patient Ambassador | completed | N/A | 23 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Feb 24, 2026 | clinicaltrials |
| NCT03005743 | Image Based Brachytherapy in Locally Advanced Cervical Cancers - a Randomized Controlled Trial(COMBAT-Cx) | completed | N/A | 1,050 | Tata Memorial HospitalOTHER_GOV | 1 | Feb 23, 2026 | clinicaltrials |
| NCT04806724 | Opening the Conversation Study | completed | N/A | 158 | Oregon State UniversityOTHER | 1 | Feb 19, 2026 | clinicaltrials |
| NCT07407179 | Quality of Life and Lymphedema After Surgical Treatment of Gynecological Malignancies | completed | N/A | 40 | Institute of Oncology LjubljanaOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT03579394 | Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer(CHRONO) | completed | N/A | 211 | ARCAGY/ GINECO GROUPOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT05870787 | iMproving thE DIagnostics And Treatment Of ceRvical Precancer(MEDIATOR) | completed | — | 929 | University of AarhusOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT07393633 | Assessing Whole-body Metabolism in Gynecologic Cancers in Response to a Single Chemotherapy Cycle and/ or Immunotherapy | completed | — | 43 | University of Tennessee Graduate School of MedicineOTHER | 1 | Feb 10, 2026 | clinicaltrials |
| NCT02195973 | Phase IB Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer | completed | Phase 1 | 15 | University of Alabama at BirminghamOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT02749110 | Participation in Screening for Cervical Cancer: Interest of a Self-sampling Device Provided by the General Practitioner(PaCUDAHL-Gé) | completed | N/A | 308 | University Hospital, LilleOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT03763838 | Acupressure for Fatigue in Ovarian Cancer Survivors | completed | N/A | 171 | University of Michigan Rogel Cancer CenterOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT03981731 | Management of Perioperative Anxiety by the Cardiac Coherence Technique Coupled With a Hypnosis Session(COHEC) | completed | N/A | 53 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT03635567 | Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826) | completed | Phase 3 | 617 | Merck Sharp & Dohme LLCINDUSTRY | 19 | Feb 4, 2026 | clinicaltrials |
| NCT03707574 | Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study | completed | — | 64 | National Cancer Institute (NCI)NIH | 2 | Feb 4, 2026 | clinicaltrials |
| NCT04457089 | Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer | completed | Early Phase 1 | 18 | Marc GoodmanOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT06086665 | The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian Cancer(REFIRM) | completed | — | 850 | Asan Medical CenterOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT06662136 | The Effect of Motivational Interviewing on HPV-DNA Testing | completed | N/A | 90 | Muazez küçükkayaOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT07384468 | Ultrasound-Guided Stellate Ganglion Block Plus Propofol for Perimenopausal Insomnia With Anxiety(SGB-PROP-PIA) | completed | N/A | 233 | Xiaochen JiOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT07365969 | Risk of Hysterectomy at Time of Myomectomy | completed | — | 293 | Ain Shams UniversityOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT02407509 | Phase I Trial of VS-6766 Alone and in Combination With Everolimus(RAF/MEK) | completed | Phase 1 | 104 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT05646680 | A Performance Study of (Opportunistic) Salpingectomy(QOS) | completed | N/A | 115 | University Hospital, GhentOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT04089189 | Study of IMP4297 in Patients With BRCA1/2 Mutation Ovarian Cancer(SABRINA) | completed | Phase 2 | 93 | Impact Therapeutics, Inc.INDUSTRY | 1 | Jan 28, 2026 | clinicaltrials |
| NCT04640480 | Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SNB-101(SN-38) in Patients With Tumors | completed | Phase 1 | 21 | SN BioScienceINDUSTRY | 1 | Jan 27, 2026 | clinicaltrials |
| NCT03622385 | Exploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer | completed | — | 10 | Baylor Research InstituteOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT06474065 | Pregnancy Outcomes Following Myomectomy | completed | — | 150 | Centro di Ricerca Clinica SalentinoNETWORK | 1 | Jan 23, 2026 | clinicaltrials |
| NCT05360680 | A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers | completed | Phase 1 | 42 | Cue BiopharmaINDUSTRY | 1 | Jan 22, 2026 | clinicaltrials |
| NCT03578406 | HPV-E6-Specific Anti-PD1 TCR-T Cells in the Treatment of HPV-Positive NHSCC or Cervical Cancer | completed | Phase 1 | 9 | Xinqiao Hospital of ChongqingOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT05041257 | Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers(PICCOLO) | completed | Phase 2 | 79 | AbbVieINDUSTRY | 7 | Jan 9, 2026 | clinicaltrials |
| NCT06173037 | RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer | completed | Phase 2 | 43 | RemeGen Co., Ltd.INDUSTRY | 1 | Jan 7, 2026 | clinicaltrials |
| NCT07250178 | ONSD as an ICP Marker in vNOTES and TLH | completed | N/A | 66 | Saglik Bilimleri Universitesi Gazi Yasargil Training and Research HospitalOTHER | 1 | Jan 7, 2026 | clinicaltrials |
| NCT06429163 | Pre-incisional Wound INfiltration and Hypogastric PLEXus Block Using Ropivacaine in Laparoscopic Myomectomy(WINPLEX) | completed | N/A | 207 | Saint Petersburg State University, RussiaOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT06839378 | Flura-seq for Evaluating the Effects of Different Hyperthermic Intraperitoneal Chemotherapy Regimens on the Transcriptome of Pseudomyxoma Peritonei | completed | N/A | 36 | Beijing Tsinghua Chang Gung HospitalOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT00980954 | Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy | completed | Phase 3 | 236 | Radiation Therapy Oncology GroupNETWORK | 4 | Dec 31, 2025 | clinicaltrials |
| NCT07312825 | Effectiveness of Combined Fascial Plane Blocks for Postoperative Pain in Gynecologic Oncology Surgery | completed | — | 94 | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research HospitalOTHER | 1 | Dec 31, 2025 | clinicaltrials |
| NCT07306195 | Comparison Between High and Low Level Para-aortic Lymphadenectomy in High and Intermediate Risk Endometrial Carcinoma | completed | N/A | 150 | Ahmed AoufOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT05483933 | Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers | completed | Phase 1 | 86 | Shattuck Labs, Inc.INDUSTRY | 4 | Dec 23, 2025 | clinicaltrials |
| NCT06846099 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903 | completed | Phase 1 | 69 | Risen (Suzhou) Pharma Tech Co., Ltd.INDUSTRY | 1 | Dec 23, 2025 | clinicaltrials |
| NCT03027479 | Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss(METERMUS-IMC) | completed | N/A | 70 | University Hospital, ToursOTHER | 1 | Dec 22, 2025 | clinicaltrials |
| NCT02001272 | EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer(EWOC-1) | completed | Phase 2 | 120 | Hospices Civils de LyonOTHER | 6 | Dec 19, 2025 | clinicaltrials |
| NCT03959761 | Tolerance of Intraperitoneal (IP) Nivolumab After Extensive Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Ovarian Carcinoma(ICONIC) | completed | Phase 1 / Phase 2 | 22 | Hospices Civils de LyonOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT04817449 | Spectroscopy in Ovarian Cancer | completed | — | 160 | University of ExeterOTHER | 1 | Dec 19, 2025 | clinicaltrials |
| NCT03466788 | Impact of Adjuvant Chemotherapy on the Quality of Life of Patients Treated for Stage II / III Endometrial Cancer(EndoQOL) | completed | N/A | 51 | Centre Francois BaclesseOTHER | 1 | Dec 18, 2025 | clinicaltrials |
| NCT04458402 | Adjuvant Hypofractionated Whole Pelvis Radiation Therapy in Endometrial Cancer | completed | N/A | 8 | Teresa MeierOTHER | 1 | Dec 18, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Mar 9, 2026source: clinicaltrials